The Brandenburg Forum on Drugs and Development Policies promotes international drug policy dialogue on development and health policy positions and creates a more informal space in which the Comission of Narcotic Drugs can be prepared.
Every year in March, numerous diplomats meet in Vienna to shape and negotiate international drug policy. At the meeting of the United Nations Commission on Narcotic Drugs (CND), known narcotic drugs and new substances are classified and placed under international control, guidelines for national drug policies are developed and current developments and approaches to global drug policy are debated. The CND will meet for the 62nd time in 2019.
Decisions are traditionally taken by consensus among the 53 member states of the CND. Within the tight schedule of the CND meeting, it is often not possible to conduct background debates and build mutual understanding in order to develop common positions. This is why since 2016, GPDPD has been organising the Brandenburg Forum (BBF) on Drugs and Development Policies on behalf of the BMZ and under the patronage of the Federal Drug Commissioner. The platform promotes international drug policy dialogue on development and health policy positions and creates a more informal space in which the CND can be prepared.
This year, the internationally renowned BBF took place for the fourth time. 47 participants, including 32 government representatives from 19 countries who will negotiate at the 62nd CND, gathered for this event from 11 to 13 February in Liebenberg, Brandenburg, in Germany. The special feature of the forum is that representatives of civil society and international organisations as well as scientists are included in the dialogue. The aim is to ensure that international drug policy is discussed in direct relation to actual global developments and problems.
The feedback on this year's BBF was consistently positive and many participants were convinced that the content could be used for their work within the CND and at the national level. As the Forum is firmly established as a global drug policy conference after four years, the series of events will be repeated next year.